Active surveillance for low-risk prostate cancer with high tumor burden at biopsy: lessons learned from a contemporary radical prostatectomy cohort
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00345-024-05227-3.pdf
Reference22 articles.
1. IARC. WHO (2024) Data visualization tools for exploring the global cancer burden in 2020. Access date Febr 13
2. Klotz L (2022) Overdiagnosis in urologic cancer: for World Journal of Urology Symposium on active surveillance in prostate and renal cancer. World J Urol 40(1):1–8
3. Mottet N, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79(2):243–262
4. Willemse PM, Davis NF, Grivas N et al (2022) Systematic review of active surveillance for clinically localised prostate Cancer to develop recommendations regarding inclusion of Intermediate-risk Disease, Biopsy characteristics at inclusion and monitoring, and surveillance repeat Biopsy Strategy. Eur Urol 81(4):337–346
5. Lam TBL, MacLennan S, Willemse PM et al (2019) EAU-EANM-ESTRO-ESUR-SIOG prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol 76(6):790–813
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3